OPS 5-399.5 - implantation and change of a permanent venous catheter (e.g. for chemotherapy or analgesia J93
Conditions
Interventions
Group 1: open strategy: Cutdown of cephalican vein for TIVAP implantation. (using of guide wire and/or peel away sheath / vein dilatator is permitted). If the aforementioned fail, Implantation by punc
Sponsors
Klinik für Allgemein,- Viszeral,- und Transplantationschirurgie, Chirurgische Universitätsklinik Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patient with oncological disease 2. scheduled for elective implantation of TIVAP 3. primary implantation on the designated side 4. Ability of subject to understand character and individual consequences of the clinical trial 5. Written informed consent
Exclusion criteria
Exclusion criteria: 1. participation in another clinical trial which could interfere with the primary endpoint of this study 2. impaired mental state or language problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of pneumo-/hemothorax after TIVAP implantation diagnosed by means of a chest x-ray on the day of operation. Telephone interview on postoperative day 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| - Primary success rates - quality of life (EQ 5-D) - duration of intervention - mortality and morbidity until day 30. Assessment on day of operation and standardized telephone interview on day 30 post-OP | — |
Countries
Germany
Outcome results
None listed